LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 74.97 | 17.25 | 1104 | 5618 | 0.1965 | 0.6458 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 74.97 | 17.25 | 1440 | 5618 | 0.2563 | 0.6990 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 74.97 | 17.25 | 1458 | 5618 | 0.2595 | 0.7015 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 76.94 | 17.25 | 1093 | 5681 | 0.1924 | 0.6422 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 76.94 | 17.25 | 1108 | 5681 | 0.1950 | 0.6449 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 76.94 | 17.25 | 1458 | 5681 | 0.2566 | 0.6998 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 76.94 | 17.25 | 1476 | 5681 | 0.2598 | 0.7023 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 78.91 | 17.25 | 1102 | 5730 | 0.1923 | 0.6426 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 78.91 | 17.25 | 1116 | 5730 | 0.1947 | 0.6451 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 78.91 | 17.25 | 1464 | 5730 | 0.2555 | 0.6993 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 78.91 | 17.25 | 1477 | 5730 | 0.2577 | 0.7011 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 80.88 | 17.25 | 1099 | 5826 | 0.1886 | 0.6398 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 80.88 | 17.25 | 1119 | 5826 | 0.1921 | 0.6433 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 80.88 | 17.25 | 1471 | 5826 | 0.2525 | 0.6977 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 80.88 | 17.25 | 1491 | 5826 | 0.2559 | 0.7005 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 82.85 | 17.25 | 1132 | 5861 | 0.1931 | 0.6447 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 82.85 | 17.25 | 1146 | 5861 | 0.1955 | 0.6471 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 82.85 | 17.25 | 1478 | 5861 | 0.2522 | 0.6977 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 82.85 | 17.25 | 1497 | 5861 | 0.2554 | 0.7003 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 84.82 | 17.25 | 1125 | 5924 | 0.1899 | 0.6420 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 84.82 | 17.25 | 1147 | 5924 | 0.1936 | 0.6458 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 84.82 | 17.25 | 1520 | 5924 | 0.2566 | 0.7018 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 84.82 | 17.25 | 1543 | 5924 | 0.2605 | 0.7048 | MN20160310_N02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 86.79 | 17.25 | 1133 | 6008 | 0.1886 | 0.6415 | MN20160310_N02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 86.79 | 17.25 | 1158 | 6008 | 0.1927 | 0.6457 | MN20160310_N02 | C04 |